For the record - March 24, 2008
Generic drugs: An article in the March 17 Health section about the FDA’s standard of “bioequivalence” to generic drugs said that a comment by neuropsychiatrist Dr. Giuseppe Borgheini about bioequivalence was from a 2004 article in the journal Clinical Therapy. The article was actually published in a 2003 issue of Clinical Therapeutics. The same story incorrectly identified the brand name of the anti-seizure drug valproic acid as Felbatol. The correct brand name is Depakote. Also, the anti-seizure drug phenytoin was identified as Cerebyx. That’s an injectable form, however; the drug is more commonly known as Dilantin.
Sign up for Essential California
The most important California stories and recommendations in your inbox every morning.
You may occasionally receive promotional content from the Los Angeles Times.
